Granulomonocyte-associated lysosomal protein expression during in vitro expansion and differentiation of CD34+ hematopoietic progenitor cells.

Using an in vitro expansion and differentiation system for human CD34+ cord blood (CB) progenitor cells, we analyzed the induction and expression kinetics of the granulomonocyte associated lysosomal proteins myeloperoxidase (MPO), lysozyme (LZ), lactoferrin (LF), and macrosialin (CD68). Freshly isolated CD34+ CB cells were negative for LZ and LF, and only small proportions expressed MPO (4% +/- 2%) or CD68 (3% +/- 1%). Culturing of CD34+ cells for 14 days with interleukin (IL)-1, IL-3, IL-6, stem cell factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and G-CSF resulted in on average a 1,750-fold amplification of cell number, of which 83% +/- 7% were MPO+. Without addition of GM-CSF and G-CSF, lower increases in total cell numbers (mean, 211-fold) and lower proportions of MPO+ cells (54% +/- 11%) were observed. The proportion of MPO+ cells slightly exceeded but clearly correlated with the proportion of cells positive for the granulomonocyte associated surface molecules CD11b (Mac-1), CD15 (LeX), CD64 (Fc gamma RI) CD66, or CD89 (Fc alpha R). At day 14 MPO+ and LZ+ cells were virtually identical. However, at earlier time points during culture (days 4 and 7), single MPO+ or LZ+ cell populations were also observed, which only later acquired LZ and MPO, respectively. Maturation of cells into the neutrophilic pathway was indicated by the acquisition of MPO, followed by LZ. In contrast, maturation of cells into the monocytic pathway was indicated by the acquisition of LZ followed by MPO and CD14. CD68 was found to be expressed at day 4 by the majority of cells and was not restricted to the granulomonocytic cells, as cells with megakariocytic (CD41+) or erythroid (CD71hi) features were CD68+. LF expression was observed only in GM- plus G-CSF-supplemented cultures, in which only 26% +/- 5% of cells expressed LF by day 14.

[1]  O. Majdic,et al.  Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. , 1994, Cytometry.

[2]  E. Kaiserling,et al.  Assessment of the value of immunohistochemistry in the subtyping of acute leukemia on routinely processed bone marrow biopsy specimens with particular reference to macrophage-associated antibodies. , 1994, Human pathology.

[3]  B. Ziegler,et al.  Phenotype analysis of hematopoietic CD34+ cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction. , 1994, Blood.

[4]  O. Majdic,et al.  Myeloperoxidase expression in CD34+ normal human hematopoietic cells. , 1993, Blood.

[5]  D. Printz,et al.  Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis , 1993 .

[6]  S. Pileri,et al.  PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. , 1993, The American journal of pathology.

[7]  D. Simmons,et al.  Molecular Cloning of CD68, a Human Macrophage Marker Related to Lysosomal Glycoproteins , 1993 .

[8]  L. To,et al.  Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. , 1992, Blood.

[9]  P. Adeleine,et al.  Specific detection of monocytic lysozyme within normal and leukemic cells. , 1992, Blood.

[10]  J. Banchereau,et al.  Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. , 1992, Experimental hematology.

[11]  E. Thorsby,et al.  Myeloid differentiation of purified CD34+ cells after stimulation with recombinant human granulocyte-monocyte colony-stimulating factor (CSF), granulocyte-CSF, monocyte-CSF, and interleukin-3. , 1991, Blood.

[12]  F. Herrmann,et al.  Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells. , 1991, Blood.

[13]  M R Loken,et al.  Quantitative Comparison of Myeloid Antigens on Five Lineages of Mature Peripheral Blood Cells , 1990, Journal of leukocyte biology.

[14]  H. Nakauchi,et al.  Colony formation of clone-sorted human hematopoietic progenitors. , 1990, Blood.

[15]  E. Cramer,et al.  Ultrastructural Localization of Lysozyme in Human Neutrophils by Immunogold , 1987, Journal of leukocyte biology.

[16]  C. Civin,et al.  Flow cytometric analysis of human bone marrow: I. Normal erythroid development , 1987 .

[17]  D. Mason,et al.  Osteoclasts contain macrophage and megakaryocyte antigens , 1986, The Journal of pathology.

[18]  H. Stein,et al.  Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[19]  P. Meyer,et al.  The distribution of lysozyme, alpha‐1‐antitrypsin, and alpha‐1‐antichymotrypsin in normal hematopoietic cells and in myeloid leukemias: An lmmunoperoxidase study on cytocentrifuge preparations, smears, and paraffin sections , 1986, American journal of hematology.

[20]  U. Testa,et al.  Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold. , 1985, Blood.

[21]  L. Parker,et al.  Lactoferrin biosynthesis during granulocytopoiesis , 1984 .

[22]  Der,et al.  A comparison of surface marker analysis and FAB classification in acute myeloid leukemia. , 1983, Blood.

[23]  K. Pryzwansky,et al.  Immunocytochemical localization of myeloperoxidase, lactoferrin, lysozyme and neutral proteases in human monocytes and neutrophilic granulocytes. , 1978, Journal of the Reticuloendothelial Society.

[24]  B. Babior,et al.  Oxygen-dependent microbial killing by phagocytes (second of two parts). , 1978, The New England journal of medicine.

[25]  Z. Cohn,et al.  IN VITRO SYNTHESIS AND SECRETION OF LYSOZYME BY MONONUCLEAR PHAGOCYTES , 1974, The Journal of experimental medicine.

[26]  T. Ganz,et al.  Neutrophils and host defense. , 1988, California medicine.

[27]  H. Braunsteiner,et al.  Der immunzytologische Lysozymnachweis in menschlichen Blutzellen , 1969 .